Takeda Pharmaceutical Company Limited
Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1-beta-L-ribofuranosyl)-1H-benzimidazole
Last updated:
Abstract:
The invention relates to novel crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-(.beta.-L-ribofuranosyl)-1H-benzimidazo- le (Maribavir), pharmaceutical compositions thereof and their use in medical therapy.
Status:
Grant
Type:
Utility
Filling date:
22 Mar 2019
Issue date:
28 Sep 2021